Company intelligence / Profile preview

Hospitech Respiration

Petah Tikva, Central District, Israelhospitech.co.il ↗

Ownership: Private
Development stage: Commercial

Overview

Hospitech Respiration has developed commercialized medical devices for improving the safety of mechanically ventilated patients. Its AnapnoGuard system automates cuff pressure control and subglottic secretion removal. The AG Cuffill device was acquired by Medline Industries in March 2024, but the company continues to operate independently with additional products. No clinical trial results are publicly detailed.

Therapeutic areas: PulmonologyOther
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Medline Industries LP (exclusive US distribution partnership for AG Cuffill since October 2020; later acquisition of that product line)

Beyond the preview

Go deeper on Hospitech Respiration.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hospitech Respiration.

Explore the full profile